In our study, we established a potential ceRNA regulatory network involving three NRDEGs (TLR4, ELAVL1, AHR), providing new insights into AIS diagnosis and more effective targeted therapies against these NRDEGs. The gene discussed is ELAVL1; the disease is androgen insensitivity syndrome.